Roche rapidly develops a PCR test for Ebola within six days as rare Bundibugyo virus drives urgent need for detection

▤ Summary

Roche has launched a research-use-only PCR test for the rare Ebola Bundibugyo virus through its subsidiary TIB MOLBIOL. The company says it developed the assay in six days after the genome sequence became available, using its outbreak-response library and reference lab network. The test is intended to help public health laboratories and reference labs establish faster detection and surveillance during the current outbreak in Central and East Africa. Roche is also working with regional authorities to bring testing closer to outbreak frontlines and improve laboratory capacity.

▦ Linked Companies

Roche

$1B+